Biocon LimitedNSE: BIOCON

Press Release Feb 09 2024

· Issued by Biocon Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-feb-09-2024-12

Biocon Limited has informed the Exchange regarding a press release dated February 09, 2024, titled "Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab".

View Attachment

6ix hasn’t read this filing yet.

Biocon Limited on 6ix

In the deck

Earlier from Biocon

Later from Biocon

All Biocon news releases